Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis
Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis
复制标题
DOI:
10.1126/scisignal.abn8017
复制
发表时间:
2022-11-01
影响因子:
7.3
通讯作者:
Tsutsui, Hiroyuki
中科院分区:
文献类型:
--
作者:
Abe, Ko;Ikeda, Masataka;Tsutsui, Hiroyuki
Clinical use of doxorubicin (DOX) is limited because of its cardiotoxicity, referred to as DOX-induced cardiomy-opathy (DIC). Mitochondria-dependent ferroptosis, which is triggered by iron overload and excessive lipid per -oxidation, plays a pivotal role in the progression of DIC. Here, we showed that DOX accumulated in mitochondria by intercalating into mitochondrial DNA (mtDNA), inducing ferroptosis in an mtDNA content-dependent manner. In addition, DOX disrupted heme synthesis by decreasing the abundance of 5'-aminolevulinate syn-thase 1 (Alas1), the rate-limiting enzyme in this process, thereby impairing iron utilization, resulting in iron over-load and ferroptosis in mitochondria in cultured cardiomyocytes. Alas1 overexpression prevented this outcome. Administration of 5-aminolevulinic acid (5-ALA), the product of Alas1, to cultured cardiomyocytes and mice sup-pressed iron overload and lipid peroxidation, thereby preventing DOX-induced ferroptosis and DIC. Our findings reveal that the accumulation of DOX and iron in mitochondria cooperatively induces ferroptosis in cardiomyo-cytes and suggest that 5-ALA can be used as a potential therapeutic agent for DIC.